VistaGen Therapeutics (VTGN) Institutional Ownership $3.52 +0.18 (+5.39%) Closing price 04:00 PM EasternExtended Trading$3.52 0.00 (0.00%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for VistaGen Therapeutics (NASDAQ:VTGN)CurrentInstitutional OwnershipPercentage78.39%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$8.11MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$3.22M Get VTGN Insider Trade Alerts Want to know when executives and insiders are buying or selling VistaGen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data VTGN Institutional Buying and Selling by Quarter VistaGen Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Jane Street Group LLC95,051$190K0.0%N/A0.310% 8/14/2025 Stempoint Capital LP2,413,254$4.83M1.5%+2.0%7.866% 8/13/2025 Marshall Wace LLP34,638$69K0.0%N/A0.113% 8/11/2025 Persistent Asset Partners Ltd86,819$174K0.1%-28.6%0.283% 8/4/2025 AdvisorShares Investments LLC203,114$406K0.1%+27.7%0.680% 7/24/2025 Blair William & Co. IL85,866$172K0.0%-14.9%0.294% 5/16/2025 ADAR1 Capital Management LLC420,765$1.05M0.2%+246.4%1.458% 5/15/2025 Cubist Systematic Strategies LLC10,088$25K0.0%N/A0.035% 2/17/2025 Two Sigma Advisers LP12,032$35K0.0%N/A0.043% 2/17/2025 Two Sigma Investments LP137,334$405K0.0%+123.2%0.493% Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VistaGen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Stempoint Capital LP2,328,492$6.87M1.7%+26.1%8.364% 2/17/2025 Man Group plc18,338$54K0.0%N/A0.066% 2/17/2025 Millennium Management LLC38,732$114K0.0%+52.9%0.139% 2/17/2025 Bank of America Corp DE21,141$62K0.0%+1,068.0%0.076% 2/17/2025 Almitas Capital LLC254,655$751K0.2%N/A0.915% 2/14/2025 AdvisorShares Investments LLC99,810$294K0.1%+47.3%0.359% 2/14/2025 Nantahala Capital Management LLC1,981,980$5.85M0.3%+30.6%7.119% 2/14/2025 Northern Trust Corp45,211$133K0.0%-8.5%0.162% 2/14/2025 Boothbay Fund Management LLC22,415$66K0.0%N/A0.081% 2/13/2025 Renaissance Technologies LLC83,700$247K0.0%-56.1%0.301% 2/13/2025 ADAR1 Capital Management LLC121,461$358K0.1%-25.5%0.436% 2/12/2025 Landscape Capital Management L.L.C.41,804$123K0.0%N/A0.150% 2/12/2025 Blair William & Co. IL98,466$290K0.0%+11.3%0.354% 2/12/2025 JPMorgan Chase & Co.772,244$2.28M0.0%+4,826,425.0%2.774% 2/7/2025 Prosperity Wealth Management Inc.29,250$86K0.0%N/A0.105% 1/23/2025 R Squared Ltd8,610$25K0.0%N/A0.031% 11/20/2024 Virtu Financial LLC20,210$61K0.0%+30.5%0.073% 11/16/2024 Geode Capital Management LLC258,524$778K0.0%-10.9%0.929% 11/15/2024 Jane Street Group LLC19,659$59K0.0%N/A0.071% 11/15/2024 HighTower Advisors LLC20,828$64K0.0%N/A0.075% 11/13/2024 Great Point Partners LLC674,075$2.03M0.6%-55.9%2.421% 11/12/2024 Valence8 US LP34,376$103K0.0%N/A0.127% 8/15/2024 Armistice Capital LLC300,000$1.04M0.0%-17.6%1.109% 8/14/2024 Great Point Partners LLC1,529,338$5.32M1.0%-17.7%5.652% 8/12/2024 Blair William & Co. IL88,466$308K0.0%+29.2%0.327% 8/9/2024 Renaissance Technologies LLC64,900$226K0.0%-40.9%0.240% 8/8/2024 American Century Companies Inc.30,315$105K0.0%+49.1%0.112% 8/8/2024 AdvisorShares Investments LLC51,780$185K0.0%-28.2%0.192% 5/14/2024 StemPoint Capital LP1,848,582$9.29M2.5%+3.3%6.842% 5/10/2024 Acadian Asset Management LLC32,291$169K0.0%N/A0.120% Leaked Gov’t Memo Reveals $100 Trillion Deadline (Ad)Only Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.Click here now to discover the full story and how to stake your claim before this land rush goes ful5/10/2024 Vanguard Group Inc.1,793,166$9.47M0.0%-2.3%6.635% 5/9/2024 Blair William & Co. IL68,466$362K0.0%-22.2%0.253% 2/15/2024 Great Point Partners LLC1,858,735$9.55M1.6%N/A6.879% 2/15/2024 BVF Inc. IL2,000,000$10.28M0.3%N/A7.402% 2/14/2024 ADAR1 Capital Management LLC245,502$1.26M0.5%N/A0.909% 2/14/2024 AdvisorShares Investments LLC54,311$279K0.1%N/A0.201% 2/13/2024 Tower Research Capital LLC TRC9,298$48K0.0%N/A0.034% 2/13/2024 Armistice Capital LLC478,000$2.46M0.0%N/A1.769% 1/30/2024 BML Capital Management LLC150,000$771K0.6%+50.0%0.555% 11/14/2023 Schonfeld Strategic Advisors LLC138,500$726K0.0%N/A1.480% 11/9/2023 Blair William & Co. IL85,173$446K0.0%N/A0.910% 10/24/2023Raymond James & Associates10,000$52K0.0%N/A0.107% 10/23/2023 BML Capital Management LLC100,000$524K0.5%N/A1.068% 4/13/2023 Allspring Global Investments Holdings LLC212,443$26K0.0%N/A0.097% 4/11/2023 Henrickson Nauta Wealth Advisors Inc.200,000$25K0.0%N/A0.091% 2/13/2023 GSA Capital Partners LLP5,095,354$525K0.1%-2.4%2.323% 2/9/2023 MAI Capital Management617,733$64K0.0%-66.7%0.299% 1/27/2023 GPS Wealth Strategies Group LLC253,205$25K0.0%+3,444.8%0.122% 11/7/2022 Virtu Financial LLC230,742$35K0.0%N/A0.112% 8/16/2022 Commodore Capital LP13,049,079$11.48M2.4%+29.2%6.309% 8/15/2022 Acuta Capital Partners LLC11,361,451$10.00M5.6%-3.2%5.498% 8/12/2022 Dorsey & Whitney Trust CO LLC150,000$132K0.0%+100.0%0.073% 8/12/2022 Franklin Resources Inc.9,448,954$8.32M0.0%-4.9%4.573% 7/29/2022 Oak Family Advisors LLC390,742$344K0.2%+93.7%0.189% 7/29/2022 SG Americas Securities LLC29,443$26K0.0%-75.3%0.014% 7/27/2022 Assenagon Asset Management S.A.360,475$317K0.0%N/A0.174% 7/20/2022 Exchange Traded Concepts LLC29,136$26K0.0%+337.9%0.014% 7/19/2022 MAI Capital Management2,661,398$2.34M0.0%N/A1.288% 7/7/2022 Epiq Partners LLC1,301,350$1.15M0.7%+12.1%0.630% 5/16/2022Ghost Tree Capital LLC1,315,154$1.63M0.4%-34.2%0.637% 5/11/2022 Dorsey & Whitney Trust CO LLC75,000$93K0.0%+275.0%0.036% 5/11/2022 GSA Capital Partners LLP73,969$92K0.0%N/A0.036% 5/10/2022 Nicholas Investment Partners LP4,570,387$5.67M0.4%+6.6%2.213% 5/4/2022ClariVest Asset Management LLC252,700$314K0.0%-12.3%0.122% 5/3/2022 Oak Family Advisors LLC201,727$250K0.1%+9.3%0.098% 4/29/2022 SG Americas Securities LLC119,157$148K0.0%+194.5%0.058% 4/29/2022 Nisa Investment Advisors LLC80,000$99K0.0%N/A0.039% 4/27/2022 Epiq Partners LLC1,161,350$1.44M0.8%+15.9%0.562% 2/15/2022 Commodore Capital LP8,464,999$16.51M3.8%+65.2%4.239% 2/14/2022 Parallax Volatility Advisers L.P.94,941$185K0.0%N/A0.048% 2/11/2022Eagle Asset Management Inc.14,723$30K0.0%N/A0.007% 2/10/2022 Rafferty Asset Management LLC490,295$956K0.0%+98.8%0.246% 2/9/2022 Principal Financial Group Inc.149,035$291K0.0%+299.9%0.075% 2/8/2022 ProShare Advisors LLC42,391$82K0.0%+70.8%0.021% 2/8/2022 Northern Trust Corp1,954,286$3.81M0.0%-2.2%0.979% 2/7/2022 SG Americas Securities LLC40,460$79K0.0%-46.7%0.020% 2/3/2022 Advisor Group Holdings Inc.42,696$83K0.0%+45.0%0.021% 2/2/2022 New York State Common Retirement Fund367,052$716K0.0%+173.6%0.184% 2/2/2022 Oak Family Advisors LLC184,517$360K0.1%+4.7%0.092% 1/31/2022 CWM LLC13,500$26K0.0%N/A0.007% This Coin Could Explode, and it’s Hiding in Plain Sight! (Ad)The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...Click here to discover The #1 Coin To Own Right Now.1/25/2022 Epiq Partners LLC1,002,350$1.96M1.0%+9.4%0.502% 11/16/2021 Schonfeld Strategic Advisors LLC422,500$1.16M0.0%-31.1%0.212% 11/16/2021 Two Sigma Advisers LP1,109,500$3.04M0.0%+75.8%0.575% 11/16/2021 Two Sigma Investments LP1,118,684$3.07M0.0%-5.9%0.580% 11/16/2021 Commodore Capital LP5,123,509$14.04M3.7%+53.8%2.656% 11/15/2021 California State Teachers Retirement System103,192$283K0.0%-60.9%0.053% 11/15/2021 Sphera Funds Management LTD.3,824,938$10.48M0.9%-6.3%1.983% 11/15/2021 Zacks Investment Management12,000$33K0.0%N/A0.006% 11/15/2021 HighVista Strategies LLC438,239$1.20M0.8%+42.2%0.227% 11/15/2021 Franklin Resources Inc.10,118,437$27.73M0.0%+1.8%5.245% (Data available from 1/1/2016 forward) VTGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VTGN shares? During the previous two years, 36 institutional investors and hedge funds held shares of VistaGen Therapeutics. The most heavily invested institutionals were BVF Inc. IL ($10.28M), Vanguard Group Inc. ($9.47M), Nantahala Capital Management LLC ($5.85M), Stempoint Capital LP ($4.83M), JPMorgan Chase & Co. ($2.28M), Great Point Partners LLC ($2.03M), and ADAR1 Capital Management LLC ($1.05M).Learn more on VistaGen Therapeutics' institutional investors. What percentage of VistaGen Therapeutics' stock is owned by institutional investors? 78.39% of VistaGen Therapeutics' stock is owned by institutional investors. Learn more on VTGN's institutional investor holdings. Which institutional investors have been buying VistaGen Therapeutics' stock? Of the 31 institutional investors that purchased VistaGen Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2M), Great Point Partners LLC ($1.86M), JPMorgan Chase & Co. ($772.23K), StemPoint Capital LP ($586.80K), ADAR1 Capital Management LLC ($544.81K), Armistice Capital LLC ($478K), and Nantahala Capital Management LLC ($464.28K). How much institutional buying is happening at VistaGen Therapeutics? Institutional investors have bought a total of 2,865,230 shares in the last 24 months. This purchase volume represents approximately $8.11M in transactions. Which of VistaGen Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold VistaGen Therapeutics stock in the last 24 months: Great Point Partners LLC ($855.26K), Renaissance Technologies LLC ($106.90K), ADAR1 Capital Management LLC ($41.62K), Persistent Asset Partners Ltd ($34.83K), Geode Capital Management LLC ($31.57K), Blair William & Co. IL ($15K), and Northern Trust Corp ($4.22K). How much institutional selling is happening at VistaGen Therapeutics? Institutional investors have sold a total of 1,089,402 shares in the last 24 months. This volume of shares sold represents approximately $3.22M in transactions. Related Companies YMAB Major Shareholders VIGL Major Shareholders ATXS Major Shareholders FULC Major Shareholders ABEO Major Shareholders INBX Major Shareholders ADCT Major Shareholders CTMX Major Shareholders ALDX Major Shareholders BNTC Major Shareholders This page (NASDAQ:VTGN) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VistaGen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VistaGen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTGN Stock Alerts